PAK1 and prostate carcinoma: These data support the conclusion that toxicity of IPA‐3 to cancer cells is mediated in part by PAK‐1, and support the hypothesis that PAK‐1 acts as an oncogene in not only prostate cancer cells,15 but extends this hypothesis to breast cancer cells and melanoma.